Ieq Capital LLC Sells 83,236 Shares of Procter & Gamble Company (The) $PG

Ieq Capital LLC reduced its stake in Procter & Gamble Company (The) (NYSE:PG) by 33.2% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 167,388 shares of the company’s stock after selling 83,236 shares during the quarter. Ieq Capital LLC’s holdings in Procter & Gamble were worth $24,546,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in PG. BlackRock Inc. acquired a new position in shares of Procter & Gamble in the 2nd quarter worth approximately $27,862,105,000. State Street Corp raised its stake in Procter & Gamble by 1.0% during the fourth quarter. State Street Corp now owns 101,618,926 shares of the company’s stock worth $14,563,008,000 after buying an additional 984,102 shares during the last quarter. Geode Capital Management LLC raised its stake in Procter & Gamble by 3.3% during the fourth quarter. Geode Capital Management LLC now owns 62,647,882 shares of the company’s stock worth $8,962,689,000 after buying an additional 1,974,556 shares during the last quarter. Norges Bank acquired a new position in Procter & Gamble in the fourth quarter valued at $4,664,783,000. Finally, Price T Rowe Associates Inc. MD boosted its position in Procter & Gamble by 3.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 29,612,826 shares of the company’s stock valued at $4,243,815,000 after acquiring an additional 1,091,091 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Key Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Brokerages maintain a consensus “Moderate Buy” rating and an average price target of $161.19, above recent trading levels. The coverage includes an RBC “outperform” reiteration and bullish ratings from Jefferies and Wells Fargo. Procter & Gamble Given Average Recommendation of Moderate Buy
• Positive Sentiment: Investor attention is returning to PG’s dividend strength. The company’s quarterly payout of $1.0885 equals approximately $4.35 annually and a 3.0% yield, supporting its appeal as a defensive income holding. Procter & Gamble Dividend Strength Returns to Focus
• Neutral Sentiment: Two insiders sold shares to cover tax-withholding obligations tied to vested equity awards. Because these were not discretionary open-market sales, they provide limited information about management’s outlook. Procter & Gamble Insider Buying and Selling
• Neutral Sentiment: Dividend-investing commentary continues to identify PG as a long-term consumer-staples holding, though a 4.74% 10-year Treasury yield raises the return threshold for owning dividend stocks. Five Dividend Aristocrats to Own for Life
• Negative Sentiment: Chief Accounting Officer Matthew Janzaruk sold 359 shares worth $52,141, reducing his direct holdings by about 22%. The transaction is small, but the non-tax-related sale may add modest pressure to sentiment. Procter & Gamble CAO Stock Sale
• Negative Sentiment: PG’s latest results showed only 1.5% year-over-year revenue growth, revenue below expectations, and lower year-over-year EPS. With the stock valued at roughly 22 times earnings, investors may remain concerned that growth is not strong enough to justify the premium.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on PG. Argus downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a report on Friday, August 7th. BMO Capital Markets upped their target price on Procter & Gamble from $169.00 to $170.00 and gave the company an “outperform” rating in a research report on Monday, June 29th. Barclays raised their target price on Procter & Gamble from $146.00 to $152.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 21st. Citigroup lowered their target price on Procter & Gamble from $181.00 to $170.00 and set a “buy” rating for the company in a report on Thursday, July 30th. Finally, Jefferies Financial Group increased their price target on Procter & Gamble from $177.00 to $179.00 and gave the stock a “buy” rating in a report on Friday, June 26th. Thirteen investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $161.19.

Insiders Place Their Bets

In related news, insider Susan Street Whaley sold 2,238 shares of the firm’s stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $143.79, for a total value of $321,802.02. Following the completion of the transaction, the insider directly owned 26,989 shares of the company’s stock, valued at approximately $3,880,748.31. This trade represents a 7.66% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Marc S. Pritchard sold 4,030 shares of the firm’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $143.79, for a total value of $579,473.70. Following the completion of the transaction, the insider directly owned 187,001 shares of the company’s stock, valued at $26,888,873.79. The trade was a 2.11% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 6,627 shares of company stock valued at $953,417 over the last ninety days. 0.20% of the stock is currently owned by insiders.

Procter & Gamble Stock Down 0.9%

PG stock opened at $145.27 on Wednesday. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $167.25. The company has a quick ratio of 0.47, a current ratio of 0.68 and a debt-to-equity ratio of 0.43. The stock’s 50 day moving average is $147.51 and its 200-day moving average is $148.52. The firm has a market capitalization of $337.67 billion, a PE ratio of 21.94, a P/E/G ratio of 4.52 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share for the quarter, beating analysts’ consensus estimates of $1.41 by $0.02. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The company had revenue of $21.20 billion for the quarter, compared to analyst estimates of $21.38 billion. During the same period last year, the firm earned $1.48 earnings per share. The firm’s revenue was up 1.5% on a year-over-year basis. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. Sell-side analysts expect that Procter & Gamble Company will post 6.98 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 17th. Shareholders of record on Friday, July 24th were issued a dividend of $1.0885 per share. This represents a $4.35 annualized dividend and a yield of 3.0%. The ex-dividend date of this dividend was Friday, July 24th. Procter & Gamble’s dividend payout ratio is 65.71%.

Procter & Gamble Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.